Sarcopenia, Calf Circumference, and Physical Function of Elderly Women: A Cross‐Sectional Study
2003/07/31 by Yves Rolland, Valérie Lauwers‐Cances, Valérie Lauwers‐Cancès +8 · 27 citations
Medicine · #Nutrition and Health in Aging #Body Composition Measurement Techniques #Bone health and osteoporosis research
paper · doi:10.1046/j.1532-5415.2003.51362.x
Abstract
OBJECTIVES: To determine whether calf circumference (CC), related to appendicular skeletal muscle mass, can be used as a measure of sarcopenia and is related to physical function. DESIGN: Retrospective analysis of data from 1992 to 1994 of the European Patient Information and Documentation Systems Study. SETTING: Community setting in France. PARTICIPANTS: One thousand four hundred fifty-eight French women aged 70 and older without previous history of hip fracture were recruited from the electoral lists. MEASUREMENTS: Muscular mass was assessed using dual-energy x-ray absorptiometry (DEXA). CC was measured using a tape measure. Anthropometric measurements (height; weight; and waist, hip, and calf circumference), strength markers (grip strength), and self-reported physical function were also determined. Sarcopenia was defined (using DEXA) as appendicular skeletal muscle mass (weight (kg)/height (m2)) less than two standard deviations below the mean of a young female reference group. RESULTS: The prevalence of sarcopenia was 9.5%. CC was correlated with appendicular skeletal muscle mass (r = 0.63). CC under 31 cm was the best clinical indicator of sarcopenia (sensitivity = 44.3%, specificity = 91.4%). CC under 31 cm was associated with disability and self-reported physical function but not sarcopenia (defined using DEXA), independent of age, comorbidity, obesity, income, health behavior, and visual impairment. CONCLUSION: CC cannot be used to predict sarcopenia defined using DEXA but provides valuable information on muscle-related disability and physical function.
Citations
Cited by
- The effectiveness of BMI, calf circumference and mid-arm circumference in predicting subsequent mortality risk in elderly Taiwanese
- Sarcopenia and Obesity
- Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. [europepmc]
- Epidemiology and consequences of sarcopenia. [europepmc]
- Towards a definition of sarcopenia--results from epidemiologic studies. [europepmc]
- Sarcopenia: clinical evaluation, biological markers and other evaluation tools. [europepmc]
- Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. [europepmc]
- An overview of sarcopenia: facts and numbers on prevalence and clinical impact. [europepmc]
- Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. [europepmc]
- From muscle wasting to sarcopenia and myopenia: update 2012. [europepmc]
- Mortality as an adverse outcome of sarcopenia. [europepmc]
- Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. [europepmc]
- Exercise attenuates the major hallmarks of aging. [europepmc]
- Methods, diagnostic criteria, cutoff points, and prevalence of sarcopenia among older people. [europepmc]
- Clinical Screening Tools for Sarcopenia and Its Management. [europepmc]
- Sarcopenia in daily practice: assessment and management. [europepmc]
- Geriatric syndromes: new frontiers in HIV and sarcopenia. [europepmc]
- Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. [europepmc]
- Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015. [europepmc]
- Reference values for handgrip strength and their association with intrinsic capacity domains among older adults. [europepmc]
- Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living. [europepmc]
- Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review. [europepmc]
- Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. [europepmc]
- Cut-offs for calf circumference as a screening tool for low muscle mass: WASEDA'S Health Study. [europepmc]
- COVID-19 and Acute Sarcopenia. [europepmc]
- Calf circumference: cutoff values from the NHANES 1999-2006. [europepmc]
- Sarcopenic obesity in older adults: a clinical overview. [europepmc]
Related